Showing results (21-30 of 4,366) with videos related to

Sort By:
Pageof 437
Clinical Immunology (Orlando, Fla.)|May 4, 2000
Eotaxin and RANTES expression by the dermal endothelium is associated with eosinophil infiltration after ivermectin treatment of onchocerciasisP J Cooper, L A Beck, I Espinel, et al.
Clinical Immunology (Orlando, Fla.)|May 4, 2000
The complexicity of cytokine treatment in ongoing EAE induced with MBP peptide 68-86 in Lewis ratsL Y Xu, M Ishikawa, Y M Huang, et al.
Clinical Immunology (Orlando, Fla.)|April 26, 2000
The microbial product lipopolysaccharide confers diabetogenic potential on the T cell repertoire of BDC2.5/NOD mice: implications for the etiology of autoimmune diabetesB Balasa, K Van Gunst, N Sarvetnick
Clinical Immunology (Orlando, Fla.)|April 26, 2000
Intratracheal administration to the lung enhances therapeutic benefit of an MBP peptide in the treatment of murine experimental autoimmune encephalomyelitisM Pietropaolo, C D Olson, B S Reiseter, et al.
Clinical Immunology (Orlando, Fla.)|April 26, 2000
The induction of EAE is only partially dependent on TNF receptor signaling but requires the IL-1 type I receptorJ Schiffenbauer, W J Streit, E Butfiloski, et al.
Clinical Immunology (Orlando, Fla.)|May 19, 2001
Fibrosis of the lung and other tissues: new concepts in pathogenesis and treatmentP J Sime, K M O'Reilly
Clinical Immunology (Orlando, Fla.)|May 19, 2001
Collagen-induced arthritis in TNF receptor-1-deficient mice: TNF receptor-2 can modulate arthritis in the absence of TNF receptor-1Y Tada, A Ho, S Koarada, et al.
Clinical Immunology (Orlando, Fla.)|July 20, 2000
Derivation of diabetes-resistant congenic lines from the nonobese diabetic mouseM McDuffie
Clinical Immunology (Orlando, Fla.)|July 20, 2000
Noncognate binding to histones of IgG from patients with idiopathic systemic lupus erythematosusH A Gussin, H N Tselentis, M Teodorescu
Clinical Immunology (Orlando, Fla.)|January 10, 2002
Systemic and mucosal immune responses in mice after rectal and vaginal immunization with HIV-DNA vaccineKenji Hamajima, Yuka Hoshino, Ke-Qin Xin, et al.
Pageof 437